Detalhe da pesquisa
1.
Rivaroxaban in Peripheral Artery Disease after Revascularization.
N Engl J Med
; 382(21): 1994-2004, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222135
2.
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
J Vasc Surg
; 77(4): 1107-1118.e2, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470531
3.
Hybrid Revascularization for Aorto-Iliac Occlusive Disease with Common Femoral Artery Involvement: Early Outcomes of a Single Centre.
Ann Vasc Surg
; 80: 180-186, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34656721
4.
Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial.
J Am Coll Cardiol
; 78(4): 317-326, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010631
5.
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
Lancet Haematol
; 3(8): e379-87, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27476789